Ben Goldacre
See the following -
Bad Pharma: Account Of The Bottomless Corruption Of The Pharma Industry Is A Stirring Call To Arms
I mentioned in September that Ben "Bad Science" Goldacre had a new book out, Bad Pharma: How drug companies mislead doctors and harm patients. I was sure at the time that this would be the usual excellent Goldacre fare -- lucid, thorough, and important. Now that I'm back from my own book tour, I've had a chance to read it and I'm pleased (or rather, furious -- more on this later) to report that this really is the usual, excellent Goldacre stuff. Read More »
- Login to post comments
Big Pharma Plays Hide-The-Ball With Data
...[E]vidence released earlier this year by Cochrane Collaboration, a London-based nonprofit, shows that a significant amount of negative data from [Tamiflu's] clinical trials were hidden from the public. The Food and Drug Administration (FDA) knew about it, but the medical community did not; the U.S. Centers for Disease Control and Prevention (CDC), which doesn’t have the same access to unpublished data as regulators, had recommended the drug without being able to see the full picture...
- Login to post comments
Health Committee: Hidden Trial Data Should Be Opened Up
The pharmaceutical industry should introduce a new code of practice, ensuring negative trial data cannot be hidden, according to the government’s Health Committee. Read More »
- Login to post comments
How Scrutiny Of Freely Available Data Might Save The NHS Money
This week Britons were reminded yet again of the strains on the government’s finances. But another resource—data—is in abundant supply. Like governments in many other countries, Britain’s is turning more and more of its trove of information into “open data”... Read More »
- Login to post comments
Open Data Probe Shows NHS Statin Bill Twice What It Should Be
A start up using some of the flood of new government data being published says the NHS could make considerable savings on its drug expenditure if it wanted. Does it have a point? Read More »
- Login to post comments
Open Data Projects Win Wellcome Trust, NIH and HHMI Open Science Prize
The Open Science Prize, a new initiative from the US National Institutes of Health (NIH), Howard Hughes Medical Institute (HHMI) and the Wellcome Trust, encourages and supports open science approaches that generate benefit to society, advance research and spur innovation. An integral component of the selection process is demonstrated use and generation of open data, so PLOS is proud that this year’s winner of the Open Science Prize is PLOS author and evolutionary, computational biologist Trevor Bedford of the Fred Hutchinson Cancer Research Center in Seattle, Washington...
- Login to post comments
Open Health Data: An International Snapshot
The 2009 Digital Britain Report described data as ‘an innovation currency’ and ‘the lifeblood of the knowledge economy.’ We are now in 2013 and while there is tremendous buzz around open data in general, open health data is definitely lagging behind. Read More »
- Login to post comments
Open-access prescription data can save Britain's NHS millions: study
A study backed by the NHS Commissioning Board (NHSCB) has found that the sharing of publicly-available prescribing data could save the NHS in England millions of pounds a year. Read More »
- Login to post comments
Richard Smith: Is The Pharmaceutical Industry Like The Mafia?
There must be plenty of people who shudder when they hear that Peter Gøtzsche will be speaking at a meeting or see his name on the contents list of a journal. He is like the young boy who not only could see that the emperor had no clothes but also said so. [...] Read More »
- Login to post comments
What Clinical Trial Results? Now You Can See Who Isn’t Sharing Their Findings
The results for nearly half of all clinical trials conducted by big drug makers during the last decade have not been published, and one company — Ranbaxy Laboratories — has not published findings for any of the nearly three dozen trials conducted in the past 10 years, according to a new online tool. The tool was launched Thursday by AllTrials, a consortium of researchers and medical journals that has been pushing the pharmaceutical industry to do a better job of disclosing clinical trial data...
- Login to post comments
Why All Pharmaceutical Research Should Be Made Open Access
The government wants to make all publicly funded research available – but the same must be demanded of pharmas also Read More »
- Login to post comments